224 related articles for article (PubMed ID: 28234768)
1. Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome.
Tas F; Erturk K
Melanoma Res; 2017 Aug; 27(4):387-390. PubMed ID: 28234768
[TBL] [Abstract][Full Text] [Related]
2. Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival.
Tas F; Erturk K
Clin Transl Oncol; 2018 May; 20(5):607-612. PubMed ID: 28948477
[TBL] [Abstract][Full Text] [Related]
3. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma.
Tas F; Erturk K
Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319
[TBL] [Abstract][Full Text] [Related]
4. Presence of histological regression as a prognostic factor in cutaneous melanoma patients.
Tas F; Erturk K
Melanoma Res; 2016 Oct; 26(5):492-6. PubMed ID: 27380112
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.
Cappello ZJ; Augenstein AC; Potts KL; McMasters KM; Bumpous JM
Laryngoscope; 2013 Jun; 123(6):1411-5. PubMed ID: 23625541
[TBL] [Abstract][Full Text] [Related]
6. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
7. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
9. Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma.
Tas F; Erturk K
Int J Dermatol; 2022 Apr; 61(4):472-479. PubMed ID: 34633070
[TBL] [Abstract][Full Text] [Related]
10. Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study.
Xie C; Pan Y; McLean C; Mar V; Wolfe R; Kelly J
J Am Acad Dermatol; 2017 Mar; 76(3):494-498.e2. PubMed ID: 28413056
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma.
Law MM; Wong JH
Am Surg; 1994 May; 60(5):362-6. PubMed ID: 8161088
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
[TBL] [Abstract][Full Text] [Related]
13. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
14. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival].
Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO
Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837
[TBL] [Abstract][Full Text] [Related]
15. Trunk melanomas: no survival differences between lesion sites.
Tas F; Erturk K
Postgrad Med; 2022 Aug; 134(6):609-615. PubMed ID: 35584552
[TBL] [Abstract][Full Text] [Related]
16. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.
Lachiewicz AM; Berwick M; Wiggins CL; Thomas NE
Arch Dermatol; 2008 Apr; 144(4):515-21. PubMed ID: 18427046
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic and blood vasculature in primary cutaneous melanomas of the scalp and neck.
Pasquali S; Montesco MC; Ginanneschi C; Baroni G; Miracco C; Urso C; Mele F; Lombardi AR; Quaglino P; Cattaneo L; Staibano S; Botti G; Visca P; Zannoni M; Soda G; Corti B; Pilloni L; Anselmi L; Lissia A; Vannucchi M; Manieli C; Massi D
Head Neck; 2015 Nov; 37(11):1596-602. PubMed ID: 24931916
[TBL] [Abstract][Full Text] [Related]
18. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
